RxDoctor Payments DataLook up a doctor →

Ogivri: payments to doctors

Payments that named Ogivri as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$159K
Providers
925
Transactions
1,477
Average per transaction
$108

The per-transaction average — $108 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 925 providers the average total is $172, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mylan Institutional Inc.$102,51664.3%
Mylan Inc.$49,62931.1%
Biocon Biologics Inc$7,3194.6%
← All drugs & devices